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Abstract The Nef protein of HIV-1 binds to uninfected CD4+T 
lymphocytes and induces apoptotic cytolysis of the cells. We 
examined several human blood cell lines and peripheral blood 
mononuclear cells (PBMCs) for Nef-induced apoptotic cell 
death. Soluble Nef protein was shown to bind to the cell surface 
of not only CD4+T cells but also CD8+T lymphocytes, B 
lymphocytes, macrophages and neutrophils. PBMCs from 
normal subjects resisted Nef binding, and activation of the cells 
with phytohemagglutinin or concanavalin A converted the cells to 
be susceptible to the binding. Cross-Unking of the Nef proteins 
bound to the cell surfaces with anti-Nef antibody-induced 
apoptotic cytolysis of the cells. The Nef-mediated apoptosis 
occurred independently of CD95(Fas). These results suggest that 
soluble Nef protein, which is found in sera of HIV-1 infected 
patients, is involved in the destruction of a broad spectrum of 
uninfected blood cells leading to immune suppression. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
HIV-1 infects and kills CD4+T lymphocytes and macro-
phages. In addition to the viral infected cells, a variety of 
uninfected cells including CD4+T and CD8+T cells, and neu-
trophils are also extensively destroyed during the course of 
HIV-1 infection [1-3]. This is considered to result in the de-
velopment to immune suppression leading to AIDS [4]. To 
prevent the death of uninfected cells, it is important to eluci-
date the mechanisms involved in the cytolysis. We have shown 
that the Nef protein of HIV-1 is present in a soluble form in 
sera of HIV-1 infected individuals and that it binds to the cell 
surface of uninfected CD4+T cells and induces apoptotic cy-
tolysis of the cells [5-7]. The Nef-mediated cytolysis may be 
responsible, at least in part, for the depletion of CD4+T cells. 
In this communication, we report that a variety of human 
blood cells were also susceptible to Nef binding and Nef-in-
duced apoptotic cytolysis, which occurred independently of 
CD95(Fas) and required cellular activation. 
2. Materials and methods 
2.1. Soluble Nef protein 
Non-myristoylated soluble forms of recombinant Nef proteins de-
rived from the Eri and the III-B strains of HIV-1 were obtained from 
Intracel, Cambridge, USA, and Immuno Diagnostics, Inc., New 
York, USA, respectively. 
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2.2. Antibodies 
Mouse IgG monoclonal antibodies (mAbs) to the N-terminus, aa 21 
to 41, of Nef protein (BRU strain) were obtained from Advanced 
Biotechnologies, Inc., Columbia, USA. Anti-CD95(Fas) mAbs (CH-
11) were obtained from Medical and Biochemical Laboratories, Co., 
Ltd. Japan. 
2.3. Cells 
Human CD4+T cell lineage derived from cutaneous T cell lympho-
ma (H9), lymphoblastoma (CEM-5) and T cell leukemia (Jurkat), 
CD4+CD8+T cell lineage derived from lymphosarcoma (Tall-1), 
CD8+T cell lineage derived from normal peripheral blood (5B5), B 
cell lineage derived from Burkitt lymphoma (Ramos), monocyte line-
age derived from histiocytic lymphoma (U937), and neutrophil lineage 
derived from myelogenous leukemia (K562) and promyelocytic leuke-
mia (HL60) were used. Cells were grown in RPMI 1640 medium 
supplemented with 10% fetal calf serum (FCS), 100 μg/ml streptomy-
cin and 100 U/ml of penicillin. For 5B5 cells, human recombinant IL-
2 (50 U/ml) was added to the medium. Peripheral blood mononuclear 
cells (PBMCs) from healthy adults were obtained by centrifugation 
through Lymphosepal (Immuno-Biological laboratories, Japan). Cells 
were incubated for 3 days in RPMI 1640 medium supplemented with 
10% FCS in the presence of 1 μg/ml phytohemagglutinin (PHA) or 
5 μg/ml concanavalin A (ConA). 
2.4. Assay of soluble Nef protein bound to cell surfaces 
Cell suspension was incubated for 40 min at 4°C with 1 μg/ml HIV-
1 Nef protein. After washing with cold phosphate buffered saline (pH 
7.4. PBS), cells were stained with anti-Nef (N-terminus) mAb and 
FITC-conjugated secondary antibody, and analyzed by a flow cytom-
eter (FACScan, Becton Dickinson, San Jose, USA). 
2.5. Analysis of apoptotic cytolysis induced by Nef protein 
A 96-well ELISA plate (ImmunoPlate Maxsorp, Nunc, Glostrup, 
Denmark) was coated with anti-Nef mAb overnight at 4°C, and 
washed with cold PBS. Cell suspension (1 X 105/tube) in RPMI 1640 
medium supplemented with 10% FCS was incubated with various 
concentrations of Nef protein for 2 h on ice. The cells were then 
incubated in the same medium in the anti-Nef mAb-coated plate for 
48 h at 37°C. Cultured cells were harvested and then incubated with 
lysis solution (0.1% Triton X-100 and 50 μg/ml propidium iodite (PI) 
in 0.1% sodium citrate) overnight at 4°C [8]. The nuclear fraction was 
analyzed for fragmentation of chromosomal DNA by both flow cy-
tometry and pulse field gel electrophoresis (PFGE) using Apoptosis 
Ladder Detection Kit (Wako Pure Chemical Industries Ltd., Japan). 
2.6. Analysis of CD95'(Fas) -mediated apoptosis 
Cells (2xl05/well) were incubated with 1 μg/ml anti-human CD95 
mAb (CH-11) for 6 h at 37°C in a C0 2 incubator. Cultured cells were 
harvested and then incubated with lysis solution and analyzed by flow 
cytometry. 
3. Results 
3.1. Binding of HIV-1 Nef protein to uninfected human 
blood cells 
Various human blood cells were incubated with the soluble 
Nef protein and the amount of Nef protein bound to the cell 
surface was measured by flowcytometry (Fig. 1, Table 1). The 
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Fig. 1. Binding of soluble Nef protein to human blood cells. Cell suspensions were incubated without (bold lines) or with (thin lines) 1 μg/ml 
of soluble Nef protein (HIV-1 III-B strain) for 1 h at 4°C and assayed for Nef binding by FACS analysis with anti-Nef mAb and FITC-conju-
gated anti-mouse IgG Ab. (a) CEM-5, (b) H9, (c) Tall-1, (d) K562, and (e) U937 cell lines. 
Table 1 
Nef binding, Nef-induced apoptosis and Fas-induced apoptosis of human blood cells 
Cells Nature (origin) Nef binding" 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
Nef-
90 
92 
85 
75 
61 
73 
77 
80 
93 
< 5 
67 
65 
-induced apoptosis (%)b Fas-induced apoptosis (%)c 
CEM-5 CD4+T lymphocyte (lymphoblastoma) 
H9 CD4+T lymphocyte (cutaneous T cell lymphoma) 
Jurkat CD4+T lymphocyte (T cell leukemia) 
Tall-1 CD4+8+T lymphocyte (lymphosarcoma) 
5B5 CD8+ T lymphocyte (normal peripheral blood) 
Ramos B lymphocyte (Burkitt lymphoma) 
K562 Neutrophil (myelogenous leukemia) 
HL60 Neutrophil (promyelocytic leukemia) 
U937 Macrophage (histiocytic lymphoma) 
PBMC Control (normal peripheral blood) 
PBMC PHA stimulation 
ConA stimulation 
22 
86 
70 
1 
23 
3 
1 
3 
8 
2 
37 
39 
aNef binding was determined by FACS analysis. +, more than 10-fold increase in fluorescence intensity. —, no shift in fluorescence intensity. 
bDNA fragmentation after 48 h incubation with Nef protein was quantified against total DNA by FACS analysis. 
CDNA fragmentation after 6 h incubation with anti-CD95(Fas) mAb (CH-11) was quantified against total DNA by FACS analysis. 
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Fig. 2. Nef-induced apoptotic cytolysis of human blood cells. A: 
Cell suspensions were incubated with or without 30 ng/ml of Nef 
protein (HIV-1 III-B strain) for 2 h at 4°C. The cells were then cul-
tured for 48 h at 37°C in a 96-well ELISA plate coated with anti-
Nef mAb and analyzed for DNA fragmentation by FACS. Bold 
lines, control cells; thin lines, Nef-treated cells, (a) CEM-5, (b) H9 
and (c) K562 cells. B: Cell suspension was incubated with various 
concentrations of the Nef protein and apoptotic cytolysis was meas-
ured by FACS analysis. The percentage of apoptotic cells (Ml re-
gion in A) was calculated against total cells. (·) CEM-5, (D) K562, 
(O) H9 cells. 
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with PHA or ConA treatment for 2 days, PBMCs became 
positive for binding by the Nef protein. 
3.2. Apoptotic cytolysis of human blood cells by HIV-1 Nef 
protein 
Cross-linking of the HIV-1 Nef protein bound to the sur-
face of uninfected CD4+T cells induces apoptotic cytolysis 
[5,6]. Since the Nef proteins were shown to bind to various 
cell types in addition to CD4+T cells, Nef-induced apoptotic 
cytolysis was examined for these cells. Results of representa-
tive cells are shown in Fig. 2, and those obtained for all cell 
types tested are summarized in Table 1. When cells were in-
cubated for 48 h in the absence of Nef, DNA of each cell line 
was in diploid, tetraploid and intermediate forms, indicating 
that each cell suspension was a mixture of cells in Go/Gi, M 
and S phases, respectively, of cell cycle. No DNA fragmenta-
tion was found. On the other hand, when cells were incubated 
with the Nef protein at 37°C, DNA fragmentation was evi-
dent in FACS analysis; the amount of polyploid full-length 
DNA was decreased and smaller DNA fragments (Ml region) 
appeared reciprocally (Fig. 2A). Typical DNA ladder forma-
tion was also seen in PFGE analysis (Fig. 3). Analysis of the 
cells with Hoechst 33258 staining also indicated DNA frag-
mentation and electron microscopic study showed typical 
Webbing of the nucleus (data not shown). Incubation of the 
cells with Nef at 4°C showed no effect. These results indicated 
that apoptosis had occurred. The apoptotic cytolysis was de-
pendent on the amount of Nef protein and incubation period 
(Fig. 2B). Nef protein at 30 ng/well was enough to kill 1 X 105 
cells of all cell lines tested within 48 h. 
It should be noted that not only CD4+T cell lines (Jurkat, 
CEM-5 and H9), but also CD4+CD8+T cell line (Tall-1), 
CD8+T cell line (5B5), macrophage line (U937) and neutro-
phil lines (K562 and HL60) were killed by the Nef protein of 
both HIV-1 Eri and III-B strains. PBMCs from healthy con-
trols resisted the Nef-induced apoptosis, but they became sen-
sitive after activation with PHA or ConA (Table 1). The spec-
trum of cell types susceptible to the Nef-mediated cytolysis 
was identical to that of Nef binding. 
Nef protein of both Eri and III-B strains was shown to bind 
to all cell lines tested, not only CD4+T cells (Jurkat, CEM-5 
and H9) but also CD4+CD8+T cells (Tall-1), CD8+T cells 
(5B5), macrophages (U937) and neutrophils (K562 and 
HL60). On the other hand, PBMCs from healthy controls 
were negative for Nef binding. However, after activation 
Fig. 3. PFGE analysis of cellular DNA. Cells were treated with the 
Nef protein as described in the legend for Fig. 2, and cellular DNA 
was analyzed for ladder formation by PFGE. Lane M, a standard 
123 bp DNA ladder, a: Jurkat, b: H9, c: Ramos and d: K562 cells. 
(—) Control cells; (+) Nef-treated cells. 
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3.3. Nef-induced apoptotic cytolysis independent of CD95(Fas) 
Apoptosis induced by gpl20 and Tat protein of HIV-1 has 
been shown to be mediated by CD95(Fas) [9]. To clarify 
whether the Nef-induced apoptotic cytolysis is dependent on 
CD95(Fas), cell surface expression of the CD95(Fas) antigen 
was examined for each cell line. Whereas all cell types tested 
underwent Nef-induced apoptosis, only part of the cells ex-
pressed CD95(Fas) and were susceptible to apoptosis by anti-
CD95(Fas) antibody (Table 1). These results indicated that 
the Nef-induced apoptosis occurred independently of 
CD95(Fas). 
4. Discussion 
The present study confirmed our previous observation that 
the HIV-1 Nef protein possesses binding affinity to the cell 
surface of uninfected CD4+T lymphocytes and the cell bound 
Nef, upon cross-linking, induces apoptotic cytolysis of the 
cells [5-7]. We provide evidence that a wide range of human 
blood cell lines including CD4+T, CD8+T, and B lympho-
cytes, macrophages, and neutrophils could also be the target 
of Nef binding and Nef-induced apoptotic cytolysis. The re-
sults suggest the presence of a putative Nef receptor on the 
surface of these uninfected cells. Although such Nef receptor 
was not expressed on the surface of PBMCs from normal 
controls, its expression was induced by activation of the cells. 
Therefore, the Nef binding and Nef-induced apoptotic cytol-
ysis required cellular activation. Cell line cells were also, more 
or less, activated. PBMCs of HIV-1 infected patients may be 
activated to some extent by cytokines induced by HIV-1 and 
other opportunistic infections [10]. Soluble Nef protein is 
found in sera of patients at a high concentration (5-10 ng/ 
ml), which is sufficient for inducing the cytotoxicity in vitro 
[5]. Anti-Nef antibodies are also present in the sera [11]. It is, 
therefore, likely that in the patients, the soluble Nef protein 
binds to a broad spectrum of PBMCs and, upon cross-linking 
by the antibodies, it induces apoptotic cell death to these cells. 
This may explain, in part, the mechanism of loss of various 
blood cells such as CD4+T and CD8+T lymphocytes and 
neutrophils, in the course of HIV-1 infections [1-3]. It should 
be noted that uninfected B cells and macrophages were also 
susceptible in vitro to the Nef-induced cytolysis. 
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The Nef-induced apoptotic cytolysis occurred independ-
ently of cell surface expression of CD95(Fas). The spectrum 
of cell types susceptible to the Nef-induced apoptosis was 
much broader than that of CD95(Fas)-dependent apoptosis. 
The Nef-mediated apoptosis was induced with all cell types 
tested, whereas only Jurkat and H9 cells expressed CD95(Fas) 
and underwent apoptosis by anti-CD95(Fas) mAb. Similar to 
the CD95(Fas)-mediated apoptosis, however, cellular activa-
tion was required for the expression of putative Nef receptor 
and Nef-induced apoptosis. Molecular characterization of the 
putative Nef receptor, identification of the natural ligands and 
the mechanism of the apoptosis remain to be studied. 
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